Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma
Asher, Samir, Kazantzi, Aikaterini, Dekaj, Fatjon, Steventon, Luke, Khatun, Aisha, Ainley, Louise, McMillan, Annabel, Rabin, Neil, Wechalekar, Ashu, Sive, Jonathan, Kyriakou, Charalampia, Papanikolaou, Xenofon, Xu, Ke, Mahmood, Shameem, Wisniowski, Brendan, Lee, Lydia, Yong, Kwee, Popat, Rakesh
Published in Haematologica (Roma) (01.12.2022)
Published in Haematologica (Roma) (01.12.2022)
Get full text
Journal Article
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial
Royle, Kara-Louise, Coulson, Amy Beth, Ramasamy, Karthik, Cairns, David A, Hockaday, Anna, Quezada, Sergio, Drayson, Mark, Kaiser, Martin, Owen, Roger, Auner, Holger W, Cook, Gordon, Meads, David, Olivier, Catherine, Barnard, Lorna, Lambkin, Rhiannon, Paterson, Andrea, Dawkins, Bryony, Chapman, Mike, Pratt, Guy, Popat, Rakesh, Jackson, Graham, Bygrave, Ceri, Sive, Jonathan, de Tute, Ruth, Chantry, Andrew, Parrish, Christopher, Cook, Mark, Asher, Samir, Yong, Kwee
Published in BMJ open (17.11.2022)
Published in BMJ open (17.11.2022)
Get full text
Journal Article
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co‐morbidities: Single‐centre experience
Melotti, Dario, Asher, Samir, Troy‐Barnes, Ethan, Nesr, George, Wilson, William, Camilleri, Marquita, Popat, Rakesh, Xu, Ke, Rabin, Neil, Sive, Jonathan, Papanikolaou, Xenofon, Lee, Lydia, McMillan, Annabel, Yong, Kwee, Kyriakou, Chara
Published in EJHaem (01.10.2024)
Published in EJHaem (01.10.2024)
Get full text
Journal Article
PB2091: DISPARITIES IN ENROLMENT INTO MULTIPLE MYELOMA CLINICAL TRIALS BY SOCIOECONOMIC DEPRIVATION
Sridhar, Amrutha, Chavda, Selina, Hsu, Hannah, Renshaw, Hanna, Fernandes, Tatianna, Maciter, Catriona, Asher, Samir, Rabin, Neil, Sive, Jonathan, Kyriakou, Charalampia, Papanikolaou, Xenofon, Xu, Ke, Wechalekar, Ashutosh, Mahmood, Shameem, Mcmillan, Annabel, Lee, Lydia, Yong, Kwee, Dekaj, Fatjon, Popat, Rakesh
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Effective Targeting of Evolutions in Concerns Underpinning COVID Vaccine Hesitancy in Patients with Sickle Cell Disease across the Lifespan of the COVID19 Pandemic
Oram, Sarah Helen, Ei, Shwe, Shankarghatta, Rohan, Sathyanath, Ananth, Hilary, Benji, Yeghen, Tullie, Asher, Samir, Sharif, Seraj, Shastri, Oliver
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
First-in-human phase I study of a ROR1-targeting bispecific T-cell engager (NVG-111) shows evidence of efficacy in patients with relapsed/refractory CLL and MCL
Jasani, Parag, Townsend, William, Asher, Samir, Tayabali, Sarrah, Tucker, David, Cook, Sarah, Batten, Toby, Granger, David, Shah, Mittal, O'Donovan, Kieran, Nathwani, Amit C.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation
Yong, Kwee, Royle, Kara-Louise, Ramasamy, Karthik, Parrish, Christopher, Hockaday, Anna, Asher, Samir, Drayson, Mark T, de Tute, Ruth M., Jenner, Matthew W, Kaiser, Martin F., Pratt, Guy, Sive, Jonathan, Bygrave, Ceri, Cook, Gordon, Popat, Rakesh, Smith, Dean, Olivier, Catherine, Barnard, Lorna, Levinte, Doina, Dawkins, Bryony, Chapman, Michael A, Chantry, Andrew D, Jackson, Graham, Quezada, Sergio A, Owen, Roger G, Cairns, David
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
P-479 Disparities in clinical trial enrolment and survival outcomes by socio-economic class in multiple myeloma
Sridhar, Amrutha, Chavda, Selina, Hsu, Hannah, Renshaw, Hanna, Dekaj, Fatjon, Asher, Samir, Mactier, Catriona, Tattersfield, Shumi, Rabin, Neil, Yong, Kwee, Wechalekar, Ashutosh, Mahmood, Ayesha Shameem, Lee, Lydia, McMillan, Annabel, Papanikolaou, Xenofon, Sive, Jonathan, Kyriakou, Charalampia, Popat, Rakesh
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience
Nesr, George, Shah, Raakhee, Kyriakou, Charalampia, Sive, Jonathan, Popat, Rakesh, Yong, Kwee, Wisniowski, Brendan, Xu, Ke, Wechalekar, Ashu, Lee, Lydia, Ings, Stuart, Papanikolaou, Xenofon, Mahmood, Shameem, Mcmillan, Annabel, Horder, Jackie, Newrick, Fiona, Marfil, Jotham, Ainley, Louise, Asher, Samir, Cheesman, Simon, Rabin, Neil
Published in Leukemia & lymphoma (03.07.2023)
Published in Leukemia & lymphoma (03.07.2023)
Get full text
Journal Article
P-322 Real world outcomes of belantamab mafodotin from the UK and Ireland: updated results
Watson, Edmund, Djebbari, Faouzi, Panitsas, Fotios, Vallance, Grant, Asher, Samir, Saeed, Malahat, Salhan, Beena, Walker, Mairi, Rampotas, Alexandros, Leary, Heather, Khera, Akhil, Atkinson, Angharad, Aung, Ni Ni, Brearton, Gillian, Froggatt, Joseph, Hassadi, Ezzat El, Lawless, Sarah, Shafeek, Salim, Stirling, Carol, Oppermann, Udo, Lokare, Anand, Soutar, Richard, Popat, Rakesh, Kyriakou, Charalampia, Ramasamy, Karthik
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
Outcomes of melphalan 140 mg/m 2 followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experience
Melotti, Dario, Asher, Samir, Troy-Barnes, Ethan, Nesr, George, Wilson, William, Camilleri, Marquita, Popat, Rakesh, Xu, Ke, Rabin, Neil, Sive, Jonathan, Papanikolaou, Xenofon, Lee, Lydia, McMillan, Annabel, Yong, Kwee, Kyriakou, Chara
Published in EJHaem (01.10.2024)
Published in EJHaem (01.10.2024)
Get full text
Journal Article
P-206: Antibodies to omicron variants are maintained in newly diagnosed MM patients on lenalidomide, cyclophosphamide, bortezomib and dexamethasone (RCyBorD): results from the UK RADAR/Myeloma XV Trial
Asher, Samir, Faustini, Sian, paterson, Andrea, Royle, Kara-Louise, Coulson, Amy, Barnard, Lorna, Liaquat, Aleena, Levinte, Doina, Hockaday, Anna, Olivier, Catherine, Cairns, David, Parrish, Christopher, Cook, Gordon, Jackson, Graham, Chapman, Michael, Kaiser, Martin, Jenner, Matthew, Bygrave, Ceri, Sive, Jonathan, Popat, Rakesh, Pratt, Guy, Richter, Alex, Drayson, Mark, Ramasamy, Karthik, Yong, Kwee
Published in Clinical lymphoma, myeloma and leukemia (01.08.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.08.2022)
Get full text
Journal Article